Literature DB >> 8152908

Intermolecular disintegration and intramolecular strand transfer activities of wild-type and mutant HIV-1 integrase.

A Mazumder1, A Engelman, R Craigie, M Fesen, Y Pommier.   

Abstract

We report the activities of HIV integrase protein on a novel DNA substrate, consisting of a pair of gapped duplex molecules. Integrase catalyzed an intermolecular disintegration reaction that requires positioning of a pair of the gapped duplexes in a configuration that resembles the intgration intermediate. However, the major reaction resulted from an intramolecular reaction involving a single gapped duplex, giving rise to a hairpin. Surprisingly, a deletion mutant of integrase that lacks both the amino and carboxyl terminal regions still catalyzed the intermolecular disintegration reaction, but supported only a very low level of the intramolecular reaction. The central core region of integrase is therefore sufficient to both bind the gapped duplex DNA and juxtapose a pair of such molecules through protein-protein interactions. We suggest that the branched DNA structures of the previously reported disintegration substrate, and the intermolecular disintegration substrate described here, assist in stabilizing protein-protein interactions that otherwise require the amino and carboxy terminal regions of integrase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8152908      PMCID: PMC307927          DOI: 10.1093/nar/22.6.1037

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

Review 1.  Genetics of retroviral integration.

Authors:  S P Goff
Journal:  Annu Rev Genet       Date:  1992       Impact factor: 16.830

2.  Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus.

Authors:  S A Chow; K A Vincent; V Ellison; P O Brown
Journal:  Science       Date:  1992-02-07       Impact factor: 47.728

3.  Characterization of the forward and reverse integration reactions of the Moloney murine leukemia virus integrase protein purified from Escherichia coli.

Authors:  C B Jonsson; G A Donzella; M J Roth
Journal:  J Biol Chem       Date:  1993-01-15       Impact factor: 5.157

4.  Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding.

Authors:  F D Bushman; A Engelman; I Palmer; P Wingfield; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

Review 5.  Present status and future prospects for HIV therapies.

Authors:  M I Johnston; D F Hoth
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

6.  Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type I integrase protein.

Authors:  C Vink; A M Oude Groeneger; R H Plasterk
Journal:  Nucleic Acids Res       Date:  1993-03-25       Impact factor: 16.971

7.  Inhibitors of human immunodeficiency virus integrase.

Authors:  M R Fesen; K W Kohn; F Leteurtre; Y Pommier
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

8.  Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations.

Authors:  K A Vincent; V Ellison; S A Chow; P O Brown
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

9.  Complementation between HIV integrase proteins mutated in different domains.

Authors:  D C van Gent; C Vink; A A Groeneger; R H Plasterk
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

10.  Identification of discrete functional domains of HIV-1 integrase and their organization within an active multimeric complex.

Authors:  A Engelman; F D Bushman; R Craigie
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

View more
  25 in total

1.  Mutational analysis of RAG1 and RAG2 identifies three catalytic amino acids in RAG1 critical for both cleavage steps of V(D)J recombination.

Authors:  M A Landree; J A Wibbenmeyer; D B Roth
Journal:  Genes Dev       Date:  1999-12-01       Impact factor: 11.361

Review 2.  Allosteric inhibitor development targeting HIV-1 integrase.

Authors:  Laith Q Al-Mawsawi; Nouri Neamati
Journal:  ChemMedChem       Date:  2011-01-12       Impact factor: 3.466

3.  IHF-independent assembly of the Tn10 strand transfer transpososome: implications for inhibition of disintegration.

Authors:  Barry J Stewart; Simon J Wardle; David B Haniford
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

4.  True reversal of Mu integration.

Authors:  T K Au; Shailja Pathania; Rasika M Harshey
Journal:  EMBO J       Date:  2004-07-29       Impact factor: 11.598

5.  The dynamic Mu transpososome: MuB activation prevents disintegration.

Authors:  Kathryn M Lemberg; Caterina T H Schweidenback; Tania A Baker
Journal:  J Mol Biol       Date:  2007-10-03       Impact factor: 5.469

6.  Assembly of prototype foamy virus strand transfer complexes on product DNA bypassing catalysis of integration.

Authors:  Zhiqi Yin; Mikalai Lapkouski; Wei Yang; Robert Craigie
Journal:  Protein Sci       Date:  2012-10-26       Impact factor: 6.725

7.  Functional domains of Moloney murine leukemia virus integrase defined by mutation and complementation analysis.

Authors:  C B Jonsson; G A Donzella; E Gaucan; C M Smith; M J Roth
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

8.  Mutational scan of the human immunodeficiency virus type 2 integrase protein.

Authors:  F M van den Ent; A Vos; R H Plasterk
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

9.  Juxtaposition of two viral DNA ends in a bimolecular disintegration reaction mediated by multimers of human immunodeficiency virus type 1 or murine leukemia virus integrase.

Authors:  S A Chow; P O Brown
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Coordinated disintegration reactions mediated by Moloney murine leukemia virus integrase.

Authors:  G A Donzella; C B Jonsson; M J Roth
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.